The disclosure concerns a device for the phototherapeutic treatment of hyperbilirubinemia in newborn infants by radiation. This device ensures that at most 10% of the radiation present in the effective range of 405 to 545 nm lies below 460 nm. Adverse effects associated with the presence of radiation...http://www.google.fr/patents/US4444190?utm_source=gb-gplus-shareBrevet US4444190 - Device for the phototherapeutic treatment of hyperbilirubinemia
Device for the phototherapeutic treatment of hyperbilirubinemia
